Nfocus CardioVasc stent-graft
This article was originally published in Clinica
Executive Summary
Nfocus Neuromedical has CE marked its CardioVasc stent-graft and delivery system for sale in Eurple. The minimally-invasive device treats patients with perforated vessels, coronary artery aneurysms or saphenous vein graft lesions caused during a previous coronary bypass. Palo Alto, California-based Nfocus expects further regulatory approvals over the next 12 months. The CardioVasc is delivered during a minimally-invasive catheter procedure. It is not yet approved in the US.